Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.10) per share. This is a 92.86 percent increase over losses of $(1.40) per share from the same period last year. The company reported $20.737 million in sales this quarter. This is a 11.19 percent increase over sales of $18.650 million the same period last year.